Jiří Matuška - Concepedia

Author

Jiří Matuška

Also Known As

JIRI MATUSKA, Jana Hirmerová, Jiri Kuchar, Jiri Matuska, Jiří Matuška, Kamel Bouslama, Petr Povolny

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Jiří Matuška is an author at Charles University specializing in thrombosis, atherosclerosis, and pharmacotherapy.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	1.6K
2	Pharmacology	2	2	1.6K
3	Anesthesiology	2	2	1.6K
4	Emergency Medicine	1	1	749
5	Neurology	1	1	855

Jiří Matuška

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Sonia S. Anand, Jackie Bosch, John W. Eikelboom, The Lancet ThrombosisCardiovascular DiseaseStrokeMedicinePlacebo-controlled Trial	2017	855
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial Stuart J. Connolly, John W. Eikelboom, Jackie Bosch, The Lancet ThrombosisCardiovascular DiseaseAtherosclerosisMedicineCoronary Artery Disease	2017	749
Sulodexide for the Prevention of Recurrent Venous Thromboembolism Giuseppe Maria Andreozzi, A Bignamini, Gualtiero Palareti, Circulation	2015	127
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab Emil Hagström, Philippe Gabríel Steg, Michael Szarek, Circulation	2022	112
Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment Gregory G. Schwartz, Michael Szarek, Vera Bittner, Diabetes Care	2021	32
Stimulation TcPO2 Testing Improves Diagnosis of Peripheral Arterial Disease in Patients With Diabetic Foot Vladimı́ra Fejfarová, Jiří Matuška, Edward B. Jude, Frontiers in Endocrinology	2021	26
Microcirculatory assessment of vascular diseases Antonella Marcoccia, Peter Klein‐Weigel, Michael E. Gschwandtner, VASA	2020	16

Page 1